Argent Biopharma Health Care
Biotech Cancer Healthcare Pharmaceuticals

$TBC

High $0.05	Low $0.05	Trades -	Turnover $0	Volume 162,016
24 July 2026 at 11:19pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code RGT	Name Argent Biopharma Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Pharmaceuticals	GIC Sub Industry Pharmaceuticals
Sector Healthcare	IPO Date 2006-12-15	Fiscal Year June	Type Common Stock
Shares Outstanding 116,609,584	Shares Floated 28,654,376	Held by Insiders 63.257%	Held by Institutions 0%

Directors & Officers

Name & Education	Position
Mr. Roby Reuven Zomer	Co-Founder, MD, CEO & Chairman
Mr. Shachar Shimony	Group General Counsel
Mr. Amir Polak	Chief Pharmaceutical Development Officer
Dr. Nadya Lisovoder	Chief Medical Officer
Ms. Sasha Friedman	Head of Information Systems
Yair Tal	Chief Information Security Officer
Mr. Andrew Chapman B.Bus(Econ), DFP, GradDipAppFin	Executive Director
Sanja Cacovich	Head of Non-Pharmaceutical Operations
Mr. Rowan Harland	Company Secretary

RGT Historic Dividends

Date	Amount
We found no dividends on record for RGT.

End of Day Prices

Date	Close	Volume	Change
23-Jul	$0.06	193,999	+0.01 (14.00%)
22-Jul	$0.05	162,016	0.00 (7.41%)
21-Jul	$0.05	193,390	+0.00 (8.00%)
20-Jul	$0.05	41,541	0.00 (9.09%)
17-Jul	$0.06	55,925	-0.06 (50.00%)
18-Sep	$0.11	90,856	+0.01 (4.76%)
12-Sep	$0.11	25,155	-0.01 (8.70%)
11-Sep	$0.12	33,313	0.00 (0.00%)
05-Sep	$0.12	295,178	-0.02 (11.54%)
04-Sep	$0.13	54,793	-0.01 (7.14%)
03-Sep	$0.14	128,988	+0.01 (7.69%)
29-Aug	$0.13	53,634	-0.01 (3.70%)
28-Aug	$0.14	29,062	+0.01 (3.85%)
22-Aug	$0.13	25,218	-0.01 (3.70%)
21-Aug	$0.14	145,919	+0.06 (68.75%)
6 up, 8 down, and 1 flat days

Market Cap (23-Jul) $6,646,746	EBITDA -	PE 14.37	Book Value $-0.10
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.11	Profit Margin N/A
Operating Margin -1737.68%	ROA 243.04%	ROE 307.4%	Revenue (FY) $347,781
Revenue per Share $0.01	Gross Profit (FY) $-637,087	Q' YOY Revenue Growth 3905.1%	Q' YOY Earnings Growth -

Argent Biopharma Health Care
Biotech Cancer Healthcare Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

RGT Historic Dividends

Followers

Prices

Announcements

End of Day Prices

RGT Argent Biopharma Health Care Biotech Cancer Healthcare Pharmaceuticals

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

RGT Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Argent Biopharma Health Care
Biotech Cancer Healthcare Pharmaceuticals